Congressional trading data shows a clear focus on major technology names as key earnings dates approach. Representative Ro Khanna appears most frequently with nine trades each in MCHP and MSFT plus additional activity in NVDA, MU, TXN and PLTR. Michael McCaul, Josh Gottheimer and others including David H. McCormick and Suzan K. DelBene round out the list of disclosed participants. The filings coincide with Microsoft scheduled to report Q4 FY2026 results around July 29 and Microchip Technology set to follow in the August 4-6 window.
Analysts expect Microsoft to deliver adjusted EPS near $4.23 on revenue of approximately $87-89 billion, extending its track record of beats fueled by Azure cloud growth above 40 percent constant currency. Microchip Technology is forecasted to report Q1 FY2027 EPS between $0.67 and $0.71 with revenue around $1.46-1.49 billion after posting a revenue beat in its most recent quarter. The broader semiconductor group including MU and NVDA, which saw eight trades each in the congressional data, reflects similar positioning amid signs of cyclical recovery in chips.
Trade counts are notable: nine for both MCHP and MSFT, eight for MU and NVDA, seven for TXN and six for PLTR. These figures represent activity across buys, sells and other transactions by sitting members. The overlap between disclosure timing and upcoming earnings calendars raises questions about how lawmakers are interpreting sector momentum in cloud, AI and industrial semiconductors. Other industrials names such as MMM also appeared with six trades, suggesting some portfolio diversification beyond pure tech.
Markets will soon test whether these congressional positions prove well-timed. Both MSFT and MCHP have histories of exceeding consensus in recent quarters, yet forward guidance and AI spending trends will drive immediate reactions. The data offers retail investors a window into where elected officials have placed concentrated bets heading into one of the busiest stretches of the technology earnings calendar.
This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.